Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 128
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Anaesthesia ; 72(12): 1554-1556, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29130280
10.
14.
Anaesthesia ; 71(1): 106-8, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26566816
15.
J Physiol ; 510 ( Pt 3): 903-13, 1998 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-9660901

RESUMO

1. A clonal cell line, L-S1, has been identified from transfection of human genomic DNA into cultured mouse L-M fibroblasts. Because this transfectant cell line stably expresses a high-affinity serotonin (5-HT) transport mechanism with kinetic and pharmacological properties comparable to those of other serotonin uptake systems, it was used to investigate the mechanistic involvement of Na+ and Cl- ions in the ligand binding and kinetic uptake processes of this system. 2. Intact transfectant cells, when incubated at low temperature (4 C), enabled quantitative assessment of imipramine-displaceable 5-[3H]HT binding to the 5-HT transport system. This binding activity is insensitive to the presence of various ligands specific for 5-HT receptor subtypes. 3. Imipramine-displaceable 5-[3H]HT binding to intact L-S1 cells was shown to be a Cl--dependent but Na+-independent process. Chloride ions lack binding co-operativity in facilitating ligand binding. Changes in external Cl- concentration altered the Kd but not the Bmax of binding. 4. The overall transport activity was observed to be highly dependent on both external Na+ and Cl- concentrations, characterized by a 5-HT:Na+:Cl- coupling ratio of 1:1:1 per transport cycle. Alterations in the external concentrations of both Na+ and Cl- ions altered only the Km and not the Vmax of transport. 5. Both binding and kinetic results are consistent with kinetic modelling predictions of the Cl- ion in facilitating 5-HT binding to the transport system, and of the Na+ ion in enabling translocation of bound 5-HT across the plasma membrane. Thus, Na+ and Cl- ions facilitate mechanistically distinct and discernible functions in the transport cycle.


Assuntos
Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Proteínas de Membrana Transportadoras , Proteínas do Tecido Nervoso , Serotonina/metabolismo , Animais , Membrana Celular/metabolismo , Células Cultivadas , Cloretos/metabolismo , Fibroblastos/metabolismo , Humanos , Imipramina/metabolismo , Cinética , Ligantes , Camundongos , Modelos Neurológicos , Inibidores da Captação de Neurotransmissores/metabolismo , Ensaio Radioligante , Proteínas da Membrana Plasmática de Transporte de Serotonina , Sódio/fisiologia , Transfecção/genética
17.
J Cataract Refract Surg ; 23(2): 260-6, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9113579

RESUMO

PURPOSE: To evaluate the cytotoxicity of immunotoxin 4197X-ricin A (4197X-RA) and its ability to inhibit protein synthesis and human lens epithelial cell (LEC) proliferation on the inner surface of the lens capsule. SETTING: Houston Biotechnology, Inc., The Woodlands, Texas. METHODS: A cell culture system was established using human LECs as a model for the proliferation of remnant LECs that occurs during posterior capsule opacification (PCO) after extracapsular cataract extraction. The LEC culture system was also used in vitro for testing compounds that might inhibit this process in vivo. Human LECs were cultured on the surface of the original lens capsule fixed to collagen. Variability was reduced by dissecting each lens capsule into equivalent halves and exposing the segments to immunotoxin 4197X-RA. RESULTS: Protein synthesis and LEC proliferation were almost completely inhibited at relatively low 4197X-RA concentrations after short exposure. The inhibitory effects persisted up to 3 weeks after withdrawal of the immunotoxin and after several media exchanges. CONCLUSION: Immunotoxin 4197X-RA may help prevent PCO after primary cataract surgery.


Assuntos
Imunotoxinas/farmacologia , Cápsula do Cristalino/citologia , Ricina , Anticorpos Monoclonais , Técnicas de Cultura de Células , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Cristalinas/antagonistas & inibidores , Cristalinas/biossíntese , Células Epiteliais , Epitélio/efeitos dos fármacos , Epitélio/metabolismo , Seguimentos , Humanos , Cápsula do Cristalino/efeitos dos fármacos , Cápsula do Cristalino/metabolismo
18.
19.
Brain Res Mol Brain Res ; 19(3): 227-32, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8412566

RESUMO

A cDNA molecule encoding the human GABA transporter was synthesized by means of polymerase chain reaction (PCR) technique and used as probe for selecting a human genomic DNA fragment encoding GABA transporter. A positive clone harboring the whole gene was obtained from a human lymphocyte genomic library through utilizing the genomic 'walking' technique. The clone, designated as pHGAT, harbours a DNA fragment of about 39 kb in length inserted into the BamHI site in cosmid pWE15. The gene covers about 25 kb in length and is constituted by four EcoRI restricted fragments which are 13.7 kb, 3.1 kb, 4.2 kb and 7.2 kb long, respectively. The genomic clone contains 15 introns, including two introns prior to the initiator methionine (i.e., the translation start site is in exon 3). Eleven exons encode the twelve transmembrane regions in the transporter protein. Thus as in the case for a number of other membrane proteins, there appears to be a strong tendency for the putative transmembrane domains to be encoded by separate exons. It is noted that the structure of the human GABA transporter gene reported here differs from the mouse gene which is contains 12 introns.


Assuntos
Proteínas de Transporte/genética , Proteínas de Membrana/genética , Proteínas de Membrana Transportadoras , Proteínas do Tecido Nervoso/genética , Transportadores de Ânions Orgânicos , Ácido gama-Aminobutírico/metabolismo , Sequência de Bases , Clonagem Molecular , Éxons , Proteínas da Membrana Plasmática de Transporte de GABA , Humanos , Íntrons , Dados de Sequência Molecular
20.
Proc Natl Acad Sci U S A ; 89(24): 11745-9, 1992 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-1465391

RESUMO

Tobacco plants were genetically transformed with the gene encoding hepatitis B surface antigen (HBsAg) linked to a nominally constitutive promoter. Enzyme-linked immunoassays using a monoclonal antibody directed against human serum-derived HBsAg revealed the presence of HBsAg in extracts of transformed leaves at levels that correlated with mRNA abundance. This suggests that there were no major inherent limitations of transcription or translation of this foreign gene in plants. Recombinant HBsAg was purified from transgenic plants by immunoaffinity chromatography and examined by electron microscopy. Spherical particles with an average diameter of 22 nm were observed in negatively stained preparations. Sedimentation of transgenic plant extracts in sucrose and cesium chloride density gradients showed that the recombinant HBsAg and human serum-derived HBsAg had similar physical properties. Because the HBsAg produced in transgenic plants is antigenically and physically similar to the HBsAg particles derived from human serum and recombinant yeast, which are used as vaccines, we conclude that transgenic plants hold promise as low-cost vaccine production systems.


Assuntos
Antígenos de Superfície da Hepatite B/genética , Clonagem Molecular , Plantas Geneticamente Modificadas , Plantas Tóxicas , Proteínas Recombinantes/isolamento & purificação , Nicotiana , Vacinas Sintéticas/genética , Vacinas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA